Health and Fitness Health and Fitness
Wed, November 3, 2010
[ Wed, Nov 03rd 2010 ] - Market Wire
Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
[ Wed, Nov 03rd 2010 ] - Market Wire
TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
[ Tue, Nov 02nd 2010 ] - Market Wire
Geron Awarded Grants Under Qualifying Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
Incyte Achieves $50 Million in Milestones for Ini .. se III Clinical Trial of Novel JAK1 and JAK2 Inhi
[ Tue, Nov 02nd 2010 ] - Market Wire
Ligand Announces Approval for Revolade® in Japan
[ Tue, Nov 02nd 2010 ] - Market Wire
AtriCure Reports Third Quarter 2010 Financial Results
[ Tue, Nov 02nd 2010 ] - Market Wire
CytRx Awarded $735,000 Grant under the Qualifying Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
ACADIA Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 9, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
SAUDI ARABIA';S NATIONAL GUARD HEALTH AFFAIRS SIG .. S AND IMRIS FOR FUTURE TECHNOLOGY FOR USE IN RADI
[ Tue, Nov 02nd 2010 ] - Market Wire
ZIOPHARM Oncology Awarded $733,000 Grant under th .. . Qualified Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
Enzon Reports Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for SpeedFix
[ Tue, Nov 02nd 2010 ] - Market Wire
Cascade Technologies Corp. Enters Into Letter of Intent to Acquire Assets of AcuNetx, Inc.
[ Tue, Nov 02nd 2010 ] - Market Wire
BioScrip Names Richard M. Smith as Chief Executive Officer
[ Tue, Nov 02nd 2010 ] - Market Wire
MEDNAX Earns $1.06 Non-GAAP for 2010 Third Quarter
[ Tue, Nov 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Presentations at the 22 .. sium on Molecular Targets and Cancer Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
Pro-Pharmaceuticals to Receive $489,000 in Federa .. tin-Targeting Cancer and Liver Fibrosis Compounds
[ Tue, Nov 02nd 2010 ] - Market Wire
RXi Pharmaceuticals Awarded $1 Million in IRS Grants to Advance RNAi Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
GTx, Inc. Announces Third Quarter 2010 Financial Results Conference Call and Webcast
[ Tue, Nov 02nd 2010 ] - Market Wire
Inhibitex Announces Data Presentations at the 61s .. can Association for the Study of Liver Diseases (
[ Tue, Nov 02nd 2010 ] - Market Wire
Ligand Awarded $2 Million from U.S. Government Un .. er the Patient Protection and Affordable Care Act
[ Tue, Nov 02nd 2010 ] - Market Wire
Celldex Reports Third Quarter 2010 Financial Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Three POZEN Projects Selected for Therapeutic Discovery Grants
[ Tue, Nov 02nd 2010 ] - Market Wire
Viread® gegen Hepatitis B hlt antivirale Suppres .. stenzen ber einen Behandlungszeitraum von vier Ja
[ Tue, Nov 02nd 2010 ] - Market Wire
Viread® voor hepatitis B behoudt antivirale supp .. van resistentie gedurende behandeling van 4 jaar
[ Tue, Nov 02nd 2010 ] - Market Wire
SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10
[ Tue, Nov 02nd 2010 ] - Market Wire
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
[ Tue, Nov 02nd 2010 ] - Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010

Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2011 on November 8, 2010


Published on 2010-11-02 16:12:04 - Market Wire
  Print publication without navigation


BOULDER, Colo.--([ BUSINESS WIRE ])--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2011 on Monday, November 8, 2010, and will hold a conference call on Tuesday, November 9, 2010 at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information

Date:

 Tuesday, November 9, 2010

Time:

 9:00 a.m. eastern time

Toll-Free:

 877-419-6593

Toll:

 719-325-4760

Pass Code:

 2106248

Web Cast:

[ www.arraybiopharma.com ]

A replay of the call will be available as a webcast on [ www.arraybiopharma.com ] and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 2106248.

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to [ www.arraybiopharma.com ].

Contributing Sources